COVID-19 Impact on Global Point of Care Infectious Disease Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Point of Care Infectious Disease Revenue
• 1.4 Market Analysis by Type
  • 1.4.1 Global Point of Care Infectious Disease Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 HIV POC
  • 1.4.3 Clostridium difficile POC
  • 1.4.4 HBV POC
  • 1.4.5 Pneumonia or Streptococcus associated infections
  • 1.4.6 Respiratory syncytial virus (RSV) POC
  • 1.4.7 HPV POC
  • 1.4.8 Influenza/Flu POC
  • 1.4.9 HCV POC
  • 1.4.10 MRSA POC
  • 1.4.11 TB and drug-resistant TB POC
• 1.5 Market by Application
  • 1.5.1 Global Point of Care Infectious Disease Market Share by Application: 2020 VS 2026
  • 1.5.2 Hospitals
  • 1.5.3 Clinics
  • 1.5.4 Home
  • 1.5.5 Assisted Living Healthcare Facilities
  • 1.5.6 Laboratories
  • 1.5.7 Others
• 1.6 Coronavirus Disease 2019 (Covid-19): Point of Care Infectious Disease Industry Impact
  • 1.6.1 How the Covid-19 is Affecting the Point of Care Infectious Disease Industry
    • 1.6.1.1 Point of Care Infectious Disease Business Impact Assessment - Covid-19
    • 1.6.1.2 Supply Chain Challenges
    • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  • 1.6.2 Market Trends and Point of Care Infectious Disease Potential Opportunities in the COVID-19 Landscape
  • 1.6.3 Measures / Proposal against Covid-19
    • 1.6.3.1 Government Measures to Combat Covid-19 Impact
    • 1.6.3.2 Proposal for Point of Care Infectious Disease Players to Combat Covid-19 Impact
• 1.7 Study Objectives
• 1.8 Years Considered

2 Global Growth Trends by Regions

• 2.1 Point of Care Infectious Disease Market Perspective (2015-2026)
• 2.2 Point of Care Infectious Disease Growth Trends by Regions
  • 2.2.1 Point of Care Infectious Disease Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Point of Care Infectious Disease Historic Market Share by Regions (2015-2020)
  • 2.2.3 Point of Care Infectious Disease Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Point of Care Infectious Disease Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Point of Care Infectious Disease Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Point of Care Infectious Disease Players by Market Size
  • 3.1.1 Global Top Point of Care Infectious Disease Players by Revenue (2015-2020)
  • 3.1.2 Global Point of Care Infectious Disease Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Point of Care Infectious Disease Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Point of Care Infectious Disease Market Concentration Ratio
  • 3.2.1 Global Point of Care Infectious Disease Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Point of Care Infectious Disease Revenue in 2019
• 3.3 Point of Care Infectious Disease Key Players Head office and Area Served
• 3.4 Key Players Point of Care Infectious Disease Product Solution and Service
• 3.5 Date of Enter into Point of Care Infectious Disease Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

• 4.1 Global Point of Care Infectious Disease Historic Market Size by Type (2015-2020)
• 4.2 Global Point of Care Infectious Disease Forecasted Market Size by Type (2021-2026)

5 Point of Care Infectious Disease Breakdown Data by Application (2015-2026)

• 5.1 Global Point of Care Infectious Disease Market Size by Application (2015-2020)
• 5.2 Global Point of Care Infectious Disease Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Point of Care Infectious Disease Market Size (2015-2020)
• 6.2 Point of Care Infectious Disease Key Players in North America (2019-2020)
• 6.3 North America Point of Care Infectious Disease Market Size by Type (2015-2020)
• 6.4 North America Point of Care Infectious Disease Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Point of Care Infectious Disease Market Size (2015-2020)
• 7.2 Point of Care Infectious Disease Key Players in Europe (2019-2020)
• 7.3 Europe Point of Care Infectious Disease Market Size by Type (2015-2020)
• 7.4 Europe Point of Care Infectious Disease Market Size by Application (2015-2020)

8 China

• 8.1 China Point of Care Infectious Disease Market Size (2015-2020)
• 8.2 Point of Care Infectious Disease Key Players in China (2019-2020)
• 8.3 China Point of Care Infectious Disease Market Size by Type (2015-2020)
• 8.4 China Point of Care Infectious Disease Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Point of Care Infectious Disease Market Size (2015-2020)
• 9.2 Point of Care Infectious Disease Key Players in Japan (2019-2020)
• 9.3 Japan Point of Care Infectious Disease Market Size by Type (2015-2020)
• 9.4 Japan Point of Care Infectious Disease Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Point of Care Infectious Disease Market Size (2015-2020)
• 10.2 Point of Care Infectious Disease Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Point of Care Infectious Disease Market Size by Type (2015-2020)
• 10.4 Southeast Asia Point of Care Infectious Disease Market Size by Application (2015-2020)

11 India

• 11.1 India Point of Care Infectious Disease Market Size (2015-2020)
• 11.2 Point of Care Infectious Disease Key Players in India (2019-2020)
• 11.3 India Point of Care Infectious Disease Market Size by Type (2015-2020)
• 11.4 India Point of Care Infectious Disease Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Point of Care Infectious Disease Market Size (2015-2020)
• 12.2 Point of Care Infectious Disease Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Point of Care Infectious Disease Market Size by Type (2015-2020)
• 12.4 Central & South America Point of Care Infectious Disease Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Siemens Healthineers
  • 13.1.1 Siemens Healthineers Company Details
  • 13.1.2 Siemens Healthineers Business Overview and Its Total Revenue
  • 13.1.3 Siemens Healthineers Point of Care Infectious Disease Introduction
  • 13.1.4 Siemens Healthineers Revenue in Point of Care Infectious Disease Business (2015-2020))
  • 13.1.5 Siemens Healthineers Recent Development
• 13.2 Trivitron Healthcare
  • 13.2.1 Trivitron Healthcare Company Details
  • 13.2.2 Trivitron Healthcare Business Overview and Its Total Revenue
  • 13.2.3 Trivitron Healthcare Point of Care Infectious Disease Introduction
  • 13.2.4 Trivitron Healthcare Revenue in Point of Care Infectious Disease Business (2015-2020)
  • 13.2.5 Trivitron Healthcare Recent Development
• 13.3 F. Hoffmann-La Roche Ltd
  • 13.3.1 F. Hoffmann-La Roche Ltd Company Details
  • 13.3.2 F. Hoffmann-La Roche Ltd Business Overview and Its Total Revenue
  • 13.3.3 F. Hoffmann-La Roche Ltd Point of Care Infectious Disease Introduction
  • 13.3.4 F. Hoffmann-La Roche Ltd Revenue in Point of Care Infectious Disease Business (2015-2020)
  • 13.3.5 F. Hoffmann-La Roche Ltd Recent Development
• 13.4 Abbott
  • 13.4.1 Abbott Company Details
  • 13.4.2 Abbott Business Overview and Its Total Revenue
  • 13.4.3 Abbott Point of Care Infectious Disease Introduction
  • 13.4.4 Abbott Revenue in Point of Care Infectious Disease Business (2015-2020)
  • 13.4.5 Abbott Recent Development
• 13.5 Quest Diagnostics, Inc
  • 13.5.1 Quest Diagnostics, Inc Company Details
  • 13.5.2 Quest Diagnostics, Inc Business Overview and Its Total Revenue
  • 13.5.3 Quest Diagnostics, Inc Point of Care Infectious Disease Introduction
  • 13.5.4 Quest Diagnostics, Inc Revenue in Point of Care Infectious Disease Business (2015-2020)
  • 13.5.5 Quest Diagnostics, Inc Recent Development
• 13.6 BD & Company
  • 13.6.1 BD & Company Company Details
  • 13.6.2 BD & Company Business Overview and Its Total Revenue
  • 13.6.3 BD & Company Point of Care Infectious Disease Introduction
  • 13.6.4 BD & Company Revenue in Point of Care Infectious Disease Business (2015-2020)
  • 13.6.5 BD & Company Recent Development
• 13.7 Chembio Diagnostics Inc
  • 13.7.1 Chembio Diagnostics Inc Company Details
  • 13.7.2 Chembio Diagnostics Inc Business Overview and Its Total Revenue
  • 13.7.3 Chembio Diagnostics Inc Point of Care Infectious Disease Introduction
  • 13.7.4 Chembio Diagnostics Inc Revenue in Point of Care Infectious Disease Business (2015-2020)
  • 13.7.5 Chembio Diagnostics Inc Recent Development
• 13.8 Trinity Biotech
  • 13.8.1 Trinity Biotech Company Details
  • 13.8.2 Trinity Biotech Business Overview and Its Total Revenue
  • 13.8.3 Trinity Biotech Point of Care Infectious Disease Introduction
  • 13.8.4 Trinity Biotech Revenue in Point of Care Infectious Disease Business (2015-2020)
  • 13.8.5 Trinity Biotech Recent Development
• 13.9 Cardinal Health
  • 13.9.1 Cardinal Health Company Details
  • 13.9.2 Cardinal Health Business Overview and Its Total Revenue
  • 13.9.3 Cardinal Health Point of Care Infectious Disease Introduction
  • 13.9.4 Cardinal Health Revenue in Point of Care Infectious Disease Business (2015-2020)
  • 13.9.5 Cardinal Health Recent Development
• 13.10 Bio-Rad Labs Inc.
  • 13.10.1 Bio-Rad Labs Inc. Company Details
  • 13.10.2 Bio-Rad Labs Inc. Business Overview and Its Total Revenue
  • 13.10.3 Bio-Rad Labs Inc. Point of Care Infectious Disease Introduction
  • 13.10.4 Bio-Rad Labs Inc. Revenue in Point of Care Infectious Disease Business (2015-2020)
  • 13.10.5 Bio-Rad Labs Inc. Recent Development
• 13.11 bioMérieux SA
  • 10.11.1 bioMérieux SA Company Details
  • 10.11.2 bioMérieux SA Business Overview and Its Total Revenue
  • 10.11.3 bioMérieux SA Point of Care Infectious Disease Introduction
  • 10.11.4 bioMérieux SA Revenue in Point of Care Infectious Disease Business (2015-2020)
  • 10.11.5 bioMérieux SA Recent Development
• 13.12 Thermo Fisher Scientific Inc
  • 10.12.1 Thermo Fisher Scientific Inc Company Details
  • 10.12.2 Thermo Fisher Scientific Inc Business Overview and Its Total Revenue
  • 10.12.3 Thermo Fisher Scientific Inc Point of Care Infectious Disease Introduction
  • 10.12.4 Thermo Fisher Scientific Inc Revenue in Point of Care Infectious Disease Business (2015-2020)
  • 10.12.5 Thermo Fisher Scientific Inc Recent Development
• 13.13 Sight Diagnostics Ltd.
  • 10.13.1 Sight Diagnostics Ltd. Company Details
  • 10.13.2 Sight Diagnostics Ltd. Business Overview and Its Total Revenue
  • 10.13.3 Sight Diagnostics Ltd. Point of Care Infectious Disease Introduction
  • 10.13.4 Sight Diagnostics Ltd. Revenue in Point of Care Infectious Disease Business (2015-2020)
  • 10.13.5 Sight Diagnostics Ltd. Recent Development
• 13.14 Gene POC
  • 10.14.1 Gene POC Company Details
  • 10.14.2 Gene POC Business Overview and Its Total Revenue
  • 10.14.3 Gene POC Point of Care Infectious Disease Introduction
  • 10.14.4 Gene POC Revenue in Point of Care Infectious Disease Business (2015-2020)
  • 10.14.5 Gene POC Recent Development
• 13.15 Ortho-Clinical Diagnostics
  • 10.15.1 Ortho-Clinical Diagnostics Company Details
  • 10.15.2 Ortho-Clinical Diagnostics Business Overview and Its Total Revenue
  • 10.15.3 Ortho-Clinical Diagnostics Point of Care Infectious Disease Introduction
  • 10.15.4 Ortho-Clinical Diagnostics Revenue in Point of Care Infectious Disease Business (2015-2020)
  • 10.15.5 Ortho-Clinical Diagnostics Recent Development
• 13.16 OJ-Bio Ltd.
  • 10.16.1 OJ-Bio Ltd. Company Details
  • 10.16.2 OJ-Bio Ltd. Business Overview and Its Total Revenue
  • 10.16.3 OJ-Bio Ltd. Point of Care Infectious Disease Introduction
  • 10.16.4 OJ-Bio Ltd. Revenue in Point of Care Infectious Disease Business (2015-2020)
  • 10.16.5 OJ-Bio Ltd. Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer